Boxer Capital as of June 30, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 26 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Solid Biosciences | 11.2 | $99M | 2.8M | 35.63 | |
| Beigene (ONC) | 11.0 | $97M | 630k | 153.73 | |
| Mirati Therapeutics | 8.7 | $77M | 1.6M | 49.30 | |
| Ptc Therapeutics I (PTCT) | 7.3 | $64M | 1.9M | 33.73 | |
| Odonate Therapeutics Ord | 7.1 | $62M | 2.8M | 22.08 | |
| Wave Life Sciences (WVE) | 6.9 | $61M | 1.6M | 38.25 | |
| Esperion Therapeutics (ESPR) | 6.1 | $54M | 1.4M | 39.19 | |
| Sarepta Therapeutics (SRPT) | 5.6 | $50M | 375k | 132.18 | |
| Medicines Company | 5.2 | $46M | 1.3M | 36.70 | |
| Rocket Pharmaceuticals (RCKT) | 4.4 | $39M | 2.0M | 19.63 | |
| Viking Therapeutics (VKTX) | 4.0 | $36M | 3.8M | 9.49 | |
| Cymabay Therapeutics | 3.2 | $28M | 2.1M | 13.42 | |
| Madrigal Pharmaceuticals (MDGL) | 3.0 | $27M | 95k | 279.69 | |
| Macrogenics (MGNX) | 2.9 | $26M | 1.2M | 20.65 | |
| Dbv Technologies S A | 2.3 | $21M | 1.1M | 19.29 | |
| Kiniksa Pharmaceuticals | 2.3 | $20M | 1.2M | 17.35 | |
| Gtx Inc Del | 2.3 | $20M | 1.3M | 15.31 | |
| Kura Oncology (KURA) | 1.7 | $15M | 845k | 18.20 | |
| Mei Pharma | 1.3 | $12M | 2.9M | 3.94 | |
| Reata Pharmaceuticals Inc Cl A | 1.3 | $11M | 325k | 34.97 | |
| Rigel Pharmaceuticals | 0.7 | $6.6M | 2.3M | 2.83 | |
| Bellerophon Therapeutics | 0.5 | $4.5M | 1.9M | 2.42 | |
| Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.5M | 2.1M | 2.12 | |
| Novus Therapeutics | 0.3 | $2.3M | 324k | 7.00 | |
| Regulus Therapeutics | 0.1 | $1.1M | 1.7M | 0.66 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $702k | 100k | 7.02 |
